Merus leads biotech with its innovative antibody platforms, strong financials, and promising petosemtamab targeting cancer.

A phase 3 trial plans to further assess neoadjuvant darovasertib for the potential treatment of patients with primary uveal ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

San Francisco, US Tuesday, April 1, 2025, 15:00 Hrs [IST] ...

Ziftomenib has received Breakthrough Therapy, Fast Track, and Orphan Drug Designations. The FDA has a 60-day filing review period to determine whether the NDA is complete and accepted for review; Kura ...

SAN FRANCISCO and SUZHOU, China, March 30, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutic ...

Kura Oncology, Inc. (Nasdaq: KURA, "Kura"), and Kyowa Kirin Co., Ltd. (TSE: 4151, "Kyowa Kirin"), today announced Kura submitted a New Drug Application ...

Q4 2024 Earnings Call Transcript March 27, 2025 Innate Pharma S.A. misses on earnings expectations. Reported EPS is $-0.33474 EPS, expectations were $-0.26681. Operator: Hello, and welcome to the ...

Building upon the BTD, which nipocalimab is the first and only therapeutic ... disease activity at Week 24 compared to placebo and IgG reductions of more than 77%.5 Trends of improvement were ...

Roughly 1.5 million patients in the U.S. have a prescription ... In June 2024, the FDA granted Vyznova coveted Breakthrough Therapy Designation (BTD) and Regenerative Medicine Advanced Therapy ...

PEORIA, Illinois (WMBD) – Peoria City soccer picked up a dramatic, 2-1 win over Chivas U23 as part of Copa Peoria. Peoria Notre Dame girls soccer won 5-0 over Geneseo in the match before to move ...